]>
IRCT20210808052106N1 IRCT 2022-02-28 Iran Health Insurance Organization The effect of Diet and Exercise on Fatty Liver Disease NAFLD The effect of lifestyle modification on the recovery of non-alcoholic fatty liver (NAFLD) of health insurance staff in Tabriz 2021-06-22 anticipated 50 Complete https://irct.ir/trial/57997 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Participants were randomly divided into two groups of intervention and control using random blocking method using 4 and 6 blocks by RAS (Random Allocation Software) and 1: 1 allocation ratio. In order to hide the assignment of the groups based on the random sequence of allocation by the person not involved in the research, the number was written on paper and sealed in a matte envelope. So that the researcher and the analyst will not know about the allocation concealment, Blinding description: In this study, after randomly assigning the individual to the study group, blinding the researcher and the participant in terms of nutrition counseling will not be possible, but the outcome researcher and statistical analyst will be blind. N/A Non-alcoholic fatty liver disease (NAFLD). Intervention 1: Intervention group: Group receiving diet and physical activity. Intervention 2: Control group: Group without diet and physical activity. Yes - There is a plan to make this available What will be shared: Part of the data, such as information about the main outcome When: Access period starts 6 months after the results are published To whom: Researchers working in academic and scientific institutions Conditions: Research using our study from another dimension Where to obtain: Ms. Soraya Moradi Analyst of the study Tel:009851040444 moradi.s@ihio.gov.ir How to obtain: ایمیل از طرف محقق علمی دانشگاهی و با احراز هویت محقق ظرف یک ماه امکان پذیر است Comments:
public leila javadi
No.35, rushdieh alley, saadi st., valiasr
Tabriz Iran (Islamic Republic of) 5157936534 +98 41 3333 1633 javadi.l@ihio.gov.ir Health Insurance Organization scientific leila javadi
No.35, Rushdieh Alley, Saadi Ave, valiasr
Tabriz Iran (Islamic Republic of) 5157936534 +98 41 3333 1633 javadi.l@ihio.gov.ir Health Insurance Organization Iran (Islamic Republic of) Patients with non-alcoholic fatty liverdisease 20 years 50 years Both Cardiovascular, thyroid, renal, inflammatory, autoimmune, hepatitis B and C, hereditary hemochromatosis, Wilson Alcohol consumers K76.0 Fatty (change of) liver, not elsewhere classified Prevention Prevention Intervention group: Group receiving diet and physical activity Control group: Group without diet and physical activity Aspartate trans amylase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method. Alanine amino transferase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method. Body Mass index. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Divide weight by height squared. Iran Health Insurance Organization Approved 2021-06-21 Ethics committee of Tabriz University of Medical Sciences NO.35, Roshdie Alley, Saadi Ave, valiasr Tabriz East Azarbaijan Iran (Islamic Republic of)